Misook Yu

Array ( [id] => 5985066 [patent_doc_number] => 20020098171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'NEW APPLICATION OF LYSOZYME DIMER' [patent_app_type] => new [patent_app_number] => 09/348814 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10815 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098171.pdf [firstpage_image] =>[orig_patent_app_number] => 09348814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 727417 [patent_doc_number] => 07041297 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-09 [patent_title] => 'Tumor antigen peptides originating in cyclophilin B' [patent_app_type] => utility [patent_app_number] => 09/720469 [patent_app_country] => US [patent_app_date] => 1999-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 15944 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041297.pdf [firstpage_image] =>[orig_patent_app_number] => 09720469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1065786 [patent_doc_number] => 06846912 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-25 [patent_title] => 'Antibody against LAR phosphatase subunit' [patent_app_type] => utility [patent_app_number] => 09/719272 [patent_app_country] => US [patent_app_date] => 1999-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15435 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846912.pdf [firstpage_image] =>[orig_patent_app_number] => 09719272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388054 [patent_doc_number] => 06544749 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Antibodies to leukemia inhibitory factor and their use in immunoassays' [patent_app_type] => B1 [patent_app_number] => 09/321935 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6577 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544749.pdf [firstpage_image] =>[orig_patent_app_number] => 09321935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1174473 [patent_doc_number] => 06750330 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Lyophilized tubulins' [patent_app_type] => B1 [patent_app_number] => 09/310981 [patent_app_country] => US [patent_app_date] => 1999-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8277 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750330.pdf [firstpage_image] =>[orig_patent_app_number] => 09310981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1017822 [patent_doc_number] => 06890716 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Recombinant cell line and screening method for identifying agents which regulate apoptosis and tumor suppression' [patent_app_type] => utility [patent_app_number] => 09/674876 [patent_app_country] => US [patent_app_date] => 1999-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 40 [patent_no_of_words] => 23124 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890716.pdf [firstpage_image] =>[orig_patent_app_number] => 09674876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 694232 [patent_doc_number] => 07070954 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-04 [patent_title] => 'Isolated SH3 genes associates with myeloproliferative disorders and leukemia and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/720934 [patent_app_country] => US [patent_app_date] => 1999-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 18 [patent_no_of_words] => 19630 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/070/07070954.pdf [firstpage_image] =>[orig_patent_app_number] => 09720934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 606335 [patent_doc_number] => 07153700 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-12-26 [patent_title] => 'Methods and compositions for diagnosing and predicting the behavior of cancer' [patent_app_type] => utility [patent_app_number] => 09/647115 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 17208 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153700.pdf [firstpage_image] =>[orig_patent_app_number] => 09647115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1040308 [patent_doc_number] => 06869604 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-22 [patent_title] => 'Recombinant anti-tumor RNAse' [patent_app_type] => utility [patent_app_number] => 09/622613 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16611 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/869/06869604.pdf [firstpage_image] =>[orig_patent_app_number] => 09622613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630316 [patent_doc_number] => 07132276 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-07 [patent_title] => 'Human p51 genes and gene products thereof' [patent_app_type] => utility [patent_app_number] => 09/670568 [patent_app_country] => US [patent_app_date] => 1999-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26299 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132276.pdf [firstpage_image] =>[orig_patent_app_number] => 09670568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1230416 [patent_doc_number] => 06692742 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Remedies for myeloma to be used together with nitrogen mustard antitumor agents' [patent_app_type] => B1 [patent_app_number] => 09/202802 [patent_app_country] => US [patent_app_date] => 1998-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 12652 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692742.pdf [firstpage_image] =>[orig_patent_app_number] => 09202802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 702221 [patent_doc_number] => 07064193 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-20 [patent_title] => 'Therapeutic molecules' [patent_app_type] => utility [patent_app_number] => 09/508832 [patent_app_country] => US [patent_app_date] => 1998-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 25886 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/064/07064193.pdf [firstpage_image] =>[orig_patent_app_number] => 09508832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6571216 [patent_doc_number] => 20020165378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'HUMAN MEMBRANE ANTIGEN TM4 SUPERFAMILY PROTEIN AND DNA ENCODING THIS PROTEIN' [patent_app_type] => new [patent_app_number] => 09/155008 [patent_app_country] => US [patent_app_date] => 1998-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9940 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165378.pdf [firstpage_image] =>[orig_patent_app_number] => 09155008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056320 [patent_doc_number] => 06855543 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-15 [patent_title] => 'Plasmid DNA containing reporter gene DNA and use of the same' [patent_app_type] => utility [patent_app_number] => 09/446634 [patent_app_country] => US [patent_app_date] => 1998-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9177 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855543.pdf [firstpage_image] =>[orig_patent_app_number] => 09446634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005080 [patent_doc_number] => 06905671 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-14 [patent_title] => 'Diagnostic agents and remedies for malignant tumors' [patent_app_type] => utility [patent_app_number] => 09/445963 [patent_app_country] => US [patent_app_date] => 1998-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5234 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/905/06905671.pdf [firstpage_image] =>[orig_patent_app_number] => 09445963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 765912 [patent_doc_number] => 07008765 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-07 [patent_title] => 'PCA3, PCA3 genes, and methods of use' [patent_app_type] => utility [patent_app_number] => 09/402713 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 21235 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/008/07008765.pdf [firstpage_image] =>[orig_patent_app_number] => 09402713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4375895 [patent_doc_number] => 06261562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Compounds for immunotherapy of prostate cancer and methods for their use' [patent_app_type] => 1 [patent_app_number] => 9/020956 [patent_app_country] => US [patent_app_date] => 1998-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31910 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261562.pdf [firstpage_image] =>[orig_patent_app_number] => 020956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1353126 [patent_doc_number] => 06576427 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Human cartilage glycoprotein' [patent_app_type] => B1 [patent_app_number] => 08/850348 [patent_app_country] => US [patent_app_date] => 1997-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7257 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576427.pdf [firstpage_image] =>[orig_patent_app_number] => 08850348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905645 [patent_doc_number] => 20020142295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'SEQUENCE-BASED MUTATION ANALYSIS OF NEOPLASTIC TISSUE FOR DIAGNOSIS OR PROGNOSIS OF THE NEOPLASIA' [patent_app_type] => new [patent_app_number] => 08/776044 [patent_app_country] => US [patent_app_date] => 1997-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6648 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142295.pdf [firstpage_image] =>[orig_patent_app_number] => 08776044 [rel_patent_id] =>[rel_patent_doc_number] =>)